Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Women with PCOS often have liver disease, so liver health checks are important for them.

HairMax LaserComb® effectively promotes hair growth and stops hair loss in males with androgenetic alopecia, with no serious side effects.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Finasteride may cause long-lasting sexual side effects.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Goat reproductive activity and coat growth are affected by light and temperature, with temperature altering prolactin levels and hair growth, but not melatonin or estrus onset.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.